GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human SIRT3 with elt inhibitor 11C [N-{2-[1-(6- CARBAMOYLTHIENO[3,2-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL]ETHYL}-N'- ethylthiophene-2,5-dicarboxamide]

Analyse Crystal structure of human SIRT3 with elt inhibitor 11C [N-{2-[1-(6… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4JSR
Type
protein
Length
274 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacetylase sirtuin-3, mitochondrial
EC
3.5.1.-
UniProt
Q9NTG7
Ligands
1NQ, ZN
Pockets
3 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacetylase sirtuin-3, mitochondrial (EC 3.5.1.-)protein27441% helix, 17% strandQ9NTG7

Ligands and binding sites

  • 1NQ · N-{2-[1-(6-carbamoylthieno[3,2-d]pyrimidin-4-yl)piperidin-4-yl]ethyl}-N'-ethylthiophene-2,5-dicarboxamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13440.650.80401NQ
2500.410.8215empty
31300.400.7426empty

Compared structures

  • 4JSR · Crystal Structure of human SIRT3 with ELT inhibitor 11c… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NTG7 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacetylase sirtuin-3… · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.